Clinical Study

2015-7950R Multiparametric Mri's Detection Of Clinically Significant Prostate Cancer

Posted Date: Jun 10, 2019

  • Investigator: Sadhna Verma
  • Specialties: Cancer, Oncology, Prostate Cancer
  • Type of Study: Observational/Survey

The goal of this study is to determine if Gadoxetate Sodium has the same ability as gadolinium to identify prostate cancer by comparing enhancement ratios and to test if the diagnosis from Gadoxetate Sodium-guided imaging can identify more aggressive prostate cancer that are likely to recur.


To Be Eligible You Must Be At Least 18 Years Of Age, Have Localized Prostate Cancer, Normal Liver Function, No Previous Prostatectomany, No Chronic Kidney Disease Or Pacemakers


Prostate Cancer

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.